Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon

Showing results (291-300 of 8,118) with videos related to

Pageof 812
Sort By:
Clinical Laboratory Science : Journal of the American Society for Medical Technology|September 2, 2005
Antibiotic resistance: a survival strategyAlbert T Sheldon
Journal of Psychiatric Practice|November 20, 2012
Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: Part 3. Effects of renal and hepatic impairmentSheldon H Preskorn
Journal of Psychiatric Practice|January 26, 2010
Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it mattersSheldon H Preskorn
The Journal of Orthopaedic and Sports Physical Therapy|February 1, 1994
Lifting instruction to children in an elementary schoolM R Sheldon
The Journal of Orthopaedic and Sports Physical Therapy|January 1, 1994
Comparison of two methods for calculating percent body weight on a tilt tableM R Sheldon
Clinical Pharmacokinetics|October 20, 2005
Pharmacokinetics and therapeutics of acute intramuscular ziprasidoneSheldon H Preskorn
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2019
Folate Deficiency Based Autism as an Orofacial Clefts/Neural Tube Defect Spectrum DisorderSheldon B Zablow
Journal of Psychiatric Practice|January 6, 2018
CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes-Tasimelteon as an ExampleSheldon H Preskorn
Journal of Psychiatric Practice|March 6, 2020
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 EnzymesSheldon H Preskorn
The American Journal of Managed Care|April 6, 2007
Overcoming information asymmetry in consumer-directed health plansSheldon M Retchin
Pageof 812

Showing results (291-300 of 8,118) with videos related to

Sort By:
Pageof 812
Clinical Laboratory Science : Journal of the American Society for Medical Technology|September 2, 2005
Antibiotic resistance: a survival strategyAlbert T Sheldon
Journal of Psychiatric Practice|November 20, 2012
Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: Part 3. Effects of renal and hepatic impairmentSheldon H Preskorn
Journal of Psychiatric Practice|January 26, 2010
Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it mattersSheldon H Preskorn
The Journal of Orthopaedic and Sports Physical Therapy|February 1, 1994
Lifting instruction to children in an elementary schoolM R Sheldon
The Journal of Orthopaedic and Sports Physical Therapy|January 1, 1994
Comparison of two methods for calculating percent body weight on a tilt tableM R Sheldon
Clinical Pharmacokinetics|October 20, 2005
Pharmacokinetics and therapeutics of acute intramuscular ziprasidoneSheldon H Preskorn
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2019
Folate Deficiency Based Autism as an Orofacial Clefts/Neural Tube Defect Spectrum DisorderSheldon B Zablow
Journal of Psychiatric Practice|January 6, 2018
CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes-Tasimelteon as an ExampleSheldon H Preskorn
Journal of Psychiatric Practice|March 6, 2020
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 EnzymesSheldon H Preskorn
The American Journal of Managed Care|April 6, 2007
Overcoming information asymmetry in consumer-directed health plansSheldon M Retchin
Pageof 812